S pneumoniae infection treatment: DCGI nod to Biological E 14-valent paediatric Pneumococcal Conjugate Vaccine Ruchika Sharma17 Dec 2022 11:33 AM ISTBE’s PCV14 is comparable in terms of serotype coverage for infants to the two globally approved pneumococcal conjugate vaccines Prevenar13 and Merck’s...
DCGI calls out WHO for 'prematurely' blaming Maiden Pharma for cough syrup linked deaths in Gambia Farhat Nasim16 Dec 2022 6:04 PM IST"It is clear that perhaps premature deduction was drawn on September 29th itself regarding the cause of death. Every subsequent alert or publication...
DCGI says WHO drew premature link between children deaths in Gambia, India-made cough syrups Ruchika Sharma16 Dec 2022 3:30 PM ISTThe DCGI said India has been committed to rigorous monitoring and oversight to ensure that the highest standards of manufacture are maintained in the...
Biocon in collaboration with Equillium begins Itolizumab clinical study for Ulcerative Colitis in India Ruchika Sharma15 Dec 2022 5:00 PM ISTItolizumab is a clinical-stage, first-in-class anti-CD6 monoclonal antibody that selectively targets the CD6- ALCAM pathway, which can drive several...
SII Cervical cancer vaccine CERVAVAC likely to be launched in April next year Ruchika Sharma15 Dec 2022 1:00 PM ISTSerum Institute's vaccine is likely to be available at a much lower rate.
Include intranasal COVID vaccine iNCOVACC in CoWIN portal: Bharat Biotech urges Centre Ruchika Sharma12 Dec 2022 12:30 PM ISTCurrently, Bharat Biotech's Covaxin, Serum Institute's Covishield and Covovax, Russian Sputink V, and Biological E Ltd's Corbevax are listed in the...
Administration of trial drugs Strozagel, Nuravon sans licensing authority nod: Forum absolves Apollo Group affiliate hospital, 3 doctors of medical negligence charges Farhat Nasim11 Dec 2022 6:45 PM ISTRanchi: The National Consumer Disputes Redressal Commission (NCDRC) has absolved a hospital affiliated to leading Apollo Group of hospitals, a...
DCGI allows Serum Institute to export Ebola vaccine to Uganda Ruchika Sharma9 Dec 2022 12:15 PM ISTThe approval for export comes after an application was submitted to the Drugs Controller General of India by Prakash Kumar Singh, Director, Serum...
DCGI gives nod to Bharat Biotech Intranasal 'Five Arms' COVID booster dose for restricted use Ruchika Sharma26 Nov 2022 11:30 AM ISTThe nasal vaccine can be taken after six months of the second dose. As this is non-invasive and needle-free, it becomes easy to administer.
Eli Lilly unveils DCGI approved Ramiven in India for early stage breast cancer Ruchika Sharma24 Nov 2022 4:00 PM ISTRamiven (abemaciclib) is a targeted treatment known as a CDK4/6 inhibitor.
Dr VG Somani to hold charge of DCGI post for another 3 months Ruchika Sharma16 Nov 2022 5:39 PM ISTDr Somani was appointed DCGI for a term of three years on August 14, 2019.
DCGI panel to hold discussion on intranasal "Five Arms" booster dose iNCOVACC on Nov 15: Sources Ruchika Sharma14 Nov 2022 1:30 PM ISTIt has now announced that iNCOVACC (BBV154) has received approval under Restricted Use in Emergency Situation for ages 18 and above.
